John Drayton Wise is CCO at INSMED Inc (INSM). They have made 9 open-market trades across 1 company since 2022, most recently 2025-02-07.
CIK 0001930805
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INSM | 133,015 | $14.6M |
Shares reported on the most recent Form 4, priced at the 2025-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSM | SELL | 2025-02-06 | 2025-02-07 | $80.90 | $641K | +4.6% | -8.6% | -17.9% |
| INSM | SELL · 10b5-1 | 2025-01-07 | 2025-01-10 | $65.94 | $1.1M | +20.6% | +21.1% | +0.4% |
| INSM | SELL · 10b5-1 | 2024-05-28 | 2024-05-30 | $49.64 | $469K | +8.6% | +16.4% | +34.3% |
| INSM | SELL | 2024-05-14 | 2024-05-15 | $25.47 | $259K | +94.0% | +158.1% | +208.4% |
| INSM | SELL | 2024-01-09 | 2024-01-11 | $28.78 | $107K | -4.3% | -2.9% | -0.8% |
| INSM | SELL · 10b5-1 | 2024-01-05 | 2024-01-05 | $29.32 | $34K | -1.7% | -2.3% | -5.7% |
| INSM | SELL | 2023-05-25 | 2023-05-26 | $18.95 | $128K | +7.4% | +6.8% | +17.6% |
| INSM | SELL | 2023-05-15 | 2023-05-17 | $18.44 | $53K | -0.2% | +6.8% | +20.2% |
| INSM | SELL | 2023-01-10 | 2023-01-12 | $17.96 | $14K | +12.2% | +3.0% | -13.7% |
| INSM | SELL | 2023-01-05 | 2023-01-06 | $19.74 | $23K | +8.0% | +18.5% | -8.0% |
| INSM | SELL | 2022-11-22 | 2022-11-22 | $18.84 | $270K | +6.5% | +7.0% | +8.6% |
| INSM | SELL | 2022-08-10 | 2022-08-12 | $27.79 | $7K | +1.0% | -6.0% | -27.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.